Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,614.83
(
0.20%
)
US TECH 100
29,844.20
(
0.45%
)
Dow Jones
51,194.23
(
0.23%
)
Brent Oil
94.73
(
-1.30%
)
Bitcoin
67,712.02
(
-5.12%
)
News Focus
News Focus
Post# of 198910
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

LonghornSean

Send PM Follow Ignore
Followers 19
Posts 1807
Boards Moderated 0
Alias Born 01/21/2018

LonghornSean

Re: kayak_wench post# 174878

Wednesday, 06/12/2024 12:30:49 AM

Wednesday, June 12, 2024 12:30:49 AM

Post# of 198910
Don’t discount the opportunity for a sooner than later buyout. It’s proven in animals and a cancer tumor in a dog, cat or horse is no different in humans. So it’s proven and with an IDE attached so It’s money in the bank. A perfect opportunity for any Oncology biotech with excess R&D budget in their annual plan. Spend it or lose it. Could be 1-3B candidate by the end of this fiscal year.

Let’s Go!
RDGL 2024!!
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RDGL News
More RDGL News